What Systemic Hormone Therapy Black Box Removal Means for Breast Cancer Survivors
This Viewpoint discusses the benefits and risks of systemic hormone therapy in breast cancer survivors following the US Food and Drug Administration’s removal of black box warnings from menopausal hormone therapy.
Authors
- Versha Pleasant (ORCID: https://orcid.org/0000-0003-2752-9636)
- Kari Lassen Ring (ORCID: https://orcid.org/0000-0001-5888-3713)
Institutions
- University of Michigan (US)
- Michigan Medicine (US)
- University of Virginia (US)
Publication Details
- Journal
- JAMA
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1001/jama.2026.0025
- Citations
- 1
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 30.73